2Zheng JJ,Zhu XS,Huangfu Z,et al.Crohn's disease in China's Mainland:a systematic analysis of 50 years of research[J].Chin J Dig Dis,2005,6(4):175-181.
3Loftus EV,Schoenfeld P,Sandborn WJ.The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America:a systematic review[J].Aliment Pharmacol Ther,2002,16(1):51-60.
5Ingle SB,Loftus EV Jr.The natural history of perianal Crohn's disease[J].Dig Liver Dis,2007,39(10):963-969.
6Stange EF,Travis SP,Vermeire S,et al.European evidence based consensus on the diagnosis and management of Crohn's disease:definitions and diagnosis[J].Gut,2006,55(1):1-15.
7Mekhjian HS,Switz DM,Melnyk CS,et al.Clinical features and natural history of Crohn' s disease.Gastroenterology,1979,77:898-906.
8Steinhardt HJ,Loeschke K,Kasper H,et al.European Cooperative Crohn's Disease Study (ECCDS):clinical features and natural history.Digestion,1985,31:97-108.
10Maglinte DD,Gourtsoyiannis N,Rex D,et al.Classification of small bowel Crohn's subtypes based on multimodality imaging.Radiol Clin North Am,2003,41:285-303.
2Askling J, Brandt L, Lapidus A, et al. Risk of haematopoi- etic cancer in patients with inflammatory bowel disease [ J] Gut, 2005,54(5 ) :617-622.
3Kandiel A, Fraser A G, Korelitz B I, et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine [ J ]. Gut, 2005,54 (8) :1121-1125.
4Homsak E, Micetic-Turk D, Bozic B. Autoantibodies pAN- CA, GAB and PAB in inflammatory bowel disease: preva- lence, characteristics and diagnostic value [ J ]. Wien Kiln Wochenschr, 2010,122( Suppl 2) : 19-25.
5Joosscns S, Colombel J F, Landers C, et al. Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis [ J ]. Gut, 2006,55 ( 11 ) : 1667-1669.
6Dotan I, Fishman S, Dgani Y, et al. Antibodies against lam- inaribioside and chitobioside are novel serologic markers in Crohn disease[ J]. Gastroenterology, 2006,131 (2) :366-378.
7Kim Y S, Kim Y H, Kim W H, et al. Diagnostic utility of anti-Saeeharomyees cerevisiae antibody (ASCA) and Inter- feron-gamma assay in the differential diagnosis of Crohn dis- ease and intestinal tuberculosis [ J ]. Clin Chim Aeta, 2011, 412(17-18) :1527-1532.
